日期: 2026-03-31
代码: 1875.HK
事件: 股东增减持（股东增减持）
药明生物于2026-03-31场外增持1137万股，每股均价4港元，最新持股数目4.751亿股，最新持股比例61.47% @#$ WuXi XDC Cayman Inc., a direct subsidiary of WuXi Biologics (Cayman) Inc., has received, in aggregate, valid acceptances to acquire 475,069,724 Shares under the Share Offer for HK$4.0 per Share, which was closed on 31 March 2026. For more information, and for the definitions of capitalised terms used in this paragraph, please refer to the announcement jointly issued by WuXi XDC Cayman Inc. and BioDlink International Company Limited dated 31 March 2026.